The Indian equity market witnessed a sharp sell-off on Thursday, with the Nifty50 index sliding below 24,800 and the Sensex plunging by about 500 points. The market downturn impacted several stocks, including SRF, which faced significant selling pressure in the early trading hours. However, the stock managed to recover from its day’s low later in the session.
SRF’s share price opened at Rs 2,206.30 on October 17, 2024, marking a four-month low. This level also turned out to be the lowest point of the day so far. By 11:30 am, the stock managed to trim its losses, trading 1.98% lower. Despite the slight recovery, SRF continues to trade below key moving averages, including the 20, 50, and 200-day moving averages (DMAs).
The fall in SRF’s share price can be attributed to a recent downgrade by UBS, which cited multiple growth challenges. These include weak demand in the agrochemical sector, where China is expected to gain market share, and softening demand and prices for refrigerant gases. These factors have contributed to the negative sentiment surrounding the stock.
So far in October, SRF’s share price has declined by 9.50%, and on a year-to-date (YTD) basis, the stock is down by 8.80%. The broader market weakness, combined with company-specific challenges, has put significant pressure on the stock’s performance.
Looking ahead, SRF’s Board of Directors is scheduled to meet on Tuesday, October 22, 2024, to consider and approve the company’s unaudited financial results for the quarter and half-year ending September 30, 2024. This upcoming announcement could provide further insights into the company’s performance and potential recovery path.
SRF remains a well-diversified company, with a wide range of products catering to industries such as automobiles, pharmaceuticals, air conditioning, refrigeration, food, agrochemicals, chemicals, mining, and more. Despite this diversification, ongoing growth challenges in key segments, particularly in the Chemical Business (CB) segment, continue to weigh on the company’s financial performance.
In FY24, SRF incurred a capital expenditure (capex) of Rs 22.2 billion, with 75-80% allocated towards its Chemical Business segment. However, concerns are growing regarding the lack of profitability on capital deployed, lower margins in cyclical segments, and the company’s reliance on debt-funded capex. Additionally, an elongating working capital cycle and net leverage exceeding 2.5x on a sustained basis pose risks to SRF’s financial stability.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates
Enjoy ₹0 Account Opening Charges
Join our 2 Cr+ happy customers